The Isoniazid Tablets, cataloged under National Stock Number 6505-00-655-4839, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Goldline Laboratories, Inc. Dba Goldline Laboratories. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-655-4839 |
| Primary Part Number | NDC00182-0559-10 |
| Item Name | Isoniazid Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Goldline Laboratories, Inc. Dba Goldline Laboratories |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 100.000 MILLIGRAMS ISONIAZID ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00182-0559-10 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| 01-4983 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC00002-2093-04 PRIMARY | Eli Lilly and Company (USA) |
| NDC00725-2150-10 PRIMARY | Circa Pharmaceutical Co Inc (USA) |
NSN 6505-00-655-4839 is a Isoniazid Tablets, manufactured by Goldline Laboratories, Inc. Dba Goldline Laboratories, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-655-4839 has 4 manufacturer part numbers on file: NDC00182-0559-10 (Goldline Laboratories, Inc. Dba Goldline Laboratories), 01-4983 (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC00002-2093-04 (Eli Lilly and Company), NDC00725-2150-10 (Circa Pharmaceutical Co Inc).
Key specifications for NDC00182-0559-10: Administration: ORAL; Primary Container Content Quantity: 1000.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.